Researchers from the University of Seville have participated in research to identify the molecular details of the regulation ...

By resurrecting a 3.2-billion-year-old enzyme and studying it inside living microbes, researchers at the University of Wisconsin–Madison have created a new way to improve our understanding of the ...

Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University led have uncovered how targeted lung cancer drugs alter the shape and behavior of a ...

Researchers use cryo-EM and optical tweezers to investigate how an antiviral interacts with the herpes simplex virus.

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Competitive enzyme inhibition happens when an inhibitor competes with the substrate to bind to the enzyme’s active site. This type of inhibition is characterized by the competitive inhibitor with a ...

A promising MET inhibitor failed in the clinic due to human-specific metabolism. Now its deuterated analogue, DO-2, is showing that a simple isotope swap might overcome the problem. The MET ...

Researchers studied a trypsin inhibitor from tamarind seeds (TTI) in Brazil to find new ways to control blood sugar TTI directly inhibited α-amylase, an enzyme that breaks down carbohydrates, by over ...